Pausing transplants in the face of a global pandemic: Patient survival implications
Open Access
- 7 March 2022
- journal article
- research article
- Published by SAGE Publications in Production and Operations Management
- Vol. 32 (5) , 1380-1396
Abstract
The coronavirus disease 2019 (COVID‐19) pandemic has disrupted normal operating procedures at transplant centers. With the possibility that COVID‐19 infection carries an overall 4% mortality rate and potentially a 24% mortality rate among the immunocompromised transplant recipients, many transplant centers considered the possibility of slowing down and even potentially pausing all transplants. Many proposals regarding the need for pausing organ transplants exist; however, much remains unknown. Whereas the impact of the COVID‐19 pandemic on the overall healthcare system is unknown, the potential impact of pausing organ transplants over a period can be estimated. This study presents a model for evaluating the impact of pausing liver transplants over a spectrum of model for end‐stage liver disease‐sodium (MELD‐Na) scores. Our model accounts for two potential risks of a pause: (1) the waitlist mortality of all patients who do not receive liver transplants during the pause period, and (2) the impact of a longer waiting list due to the pause of liver transplants and the continuous accrual of new patients. Using over 12 years of liver transplant data from the United Network for Organ Sharing and a system of differential equations, we estimate the threshold probability above which a decision maker should pause liver transplants to reduce the loss of patient life months. We also compare different pause policies to illustrate the value of patient‐specific and center‐specific approaches. Finally, we analyze how capacity constraints affect the loss of patient life months and the length of the waiting list. The results of this study are useful to decision makers in deciding whether and how to pause organ transplants during a pandemic. The results are also useful to patients (and their care providers) who are waiting for organ transplants.Keywords
Funding Information
- Health Resources and Services Administration (234‐2005‐370011C)
This publication has 20 references indexed in Scilit:
- Successful treatment of severe COVID-19 pneumonia in a liver transplant recipientAmerican Journal of Transplantation, 2022
- Global Transplantation COVID Report March 2020Transplantation, 2020
- COVID-19: A global transplant perspective on successfully navigating a pandemicAmerican Journal of Transplantation, 2020
- 2019-Novel Coronavirus (2019-nCoV): estimating the case fatality rate – a word of cautionSwiss Medical Weekly, 2020
- Improving Societal Outcomes in the Organ Donation Value ChainProduction and Operations Management, 2019
- Enhancing Kidney Supply Through Geographic Sharing in the United StatesProduction and Operations Management, 2018
- Big Data and the Precision Medicine RevolutionProduction and Operations Management, 2018
- MELD as a metric for survival benefit of liver transplantationAmerican Journal of Transplantation, 2018
- Survival Benefit of Solid-Organ Transplant in the United StatesJAMA Surgery, 2015
- To Be or Not to Be? That is Conception! Managing In Vitro Fertilization ProgramsManagement Science, 1992